SEC Form 4 · accession 0002111813-26-000010
Faeth Therapeutics, Inc. · FTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anand Kiran Parikh
Officer — President and CEO · Director
Period of report
Jun 22, 2026
Accepted (ET)
Jun 24, 2026 · 6:55 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001829802
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 22, 2026 | P | 2,806 | $19.76 | A | 764,234 | D | |
| Common Stock | Jun 22, 2026 | M | 45,252 | $1.16 | A | 809,486 | D | |
| Common Stock | Jun 22, 2026 | M | 8,213 | $1.16 | A | 817,699 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1,F2 | $1.16 | Jun 22, 2026 | M | 45,252 | D | — | Dec 1, 2035 | Common Stock | 45,252 | 91,632 | D |
| Employee Stock Option (right to buy)F3 | $1.16 | Jun 22, 2026 | M | 8,213 | D | — | Sep 14, 2032 | Common Stock | 8,213 | 4,107 | D |
Explanation of responses
- F1Beginning on March 1, 2026, 12,258 shares vest monthly through January 1, 2027, with the balance fully vesting on February 1, 2027.
- F2The Form 4/A filed on June 16, 2026 (the "Form 4/A") contained a clerical error with respect to the expiration date of the reported security. This Form 4 corrects that clerical error to report the expiration date of the reported security as December 1, 2035. All other information reported on the Form 4/A remains unchanged.
- F3Beginning August 1, 2022, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments.